17-44967793-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006688.5(C1QL1):c.256G>T(p.Asp86Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,456,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006688.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QL1 | NM_006688.5 | c.256G>T | p.Asp86Tyr | missense_variant | 1/2 | ENST00000253407.4 | NP_006679.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QL1 | ENST00000253407.4 | c.256G>T | p.Asp86Tyr | missense_variant | 1/2 | 1 | NM_006688.5 | ENSP00000253407.2 | ||
NMT1 | ENST00000678938.1 | c.-110+9731C>A | intron_variant | ENSP00000503621.1 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151806Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000918 AC: 5AN: 54462Hom.: 0 AF XY: 0.0000639 AC XY: 2AN XY: 31298
GnomAD4 exome AF: 0.0000299 AC: 39AN: 1304662Hom.: 0 Cov.: 32 AF XY: 0.0000296 AC XY: 19AN XY: 641120
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151916Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.256G>T (p.D86Y) alteration is located in exon 1 (coding exon 1) of the C1QL1 gene. This alteration results from a G to T substitution at nucleotide position 256, causing the aspartic acid (D) at amino acid position 86 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at